Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Reed

Showing results (101-110 of 166) with videos related to

Pageof 17
Sort By:
Journal of Clinical Microbiology|June 2, 2000
Mass spectrometric identification of mtb81, a novel serological marker for tuberculosisR C Hendrickson, J F Douglass, L D Reynolds, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 15, 2011
Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosyL H Sampaio, A L M Sousa, M C Barcelos, et al.
Infection and Immunity|October 1, 1995
Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humansY A Skeiky, D R Benson, J A Guderian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinaseA C Arnholdt, M R Piuvezam, D M Russo, et al.
The Journal of Infectious Diseases|February 1, 1993
Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania speciesW G Shreffler, J M Burns, R Badaró, et al.
The Journal of Infectious Diseases|May 21, 1998
A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapyR L Houghton, M Petrescu, D R Benson, et al.
Science (New York, N.Y.)|July 24, 1992
Transforming growth factor-beta in leishmanial infection: a parasite escape mechanismM Barral-Netto, A Barral, C E Brownell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1993
Mapping human T cell epitopes in leishmania gp63. Identification of cross-reactive and species-specific epitopesD M Russo, A Jardim, E M Carvalho, et al.
Journal of Clinical Microbiology|April 1, 1994
Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigensJ M Peralta, M G Teixeira, W G Shreffler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 1991
Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasisM Barral-Netto, A Barral, S B Santos, et al.
Pageof 17

Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
Journal of Clinical Microbiology|June 2, 2000
Mass spectrometric identification of mtb81, a novel serological marker for tuberculosisR C Hendrickson, J F Douglass, L D Reynolds, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 15, 2011
Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosyL H Sampaio, A L M Sousa, M C Barcelos, et al.
Infection and Immunity|October 1, 1995
Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humansY A Skeiky, D R Benson, J A Guderian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinaseA C Arnholdt, M R Piuvezam, D M Russo, et al.
The Journal of Infectious Diseases|February 1, 1993
Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania speciesW G Shreffler, J M Burns, R Badaró, et al.
The Journal of Infectious Diseases|May 21, 1998
A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapyR L Houghton, M Petrescu, D R Benson, et al.
Science (New York, N.Y.)|July 24, 1992
Transforming growth factor-beta in leishmanial infection: a parasite escape mechanismM Barral-Netto, A Barral, C E Brownell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1993
Mapping human T cell epitopes in leishmania gp63. Identification of cross-reactive and species-specific epitopesD M Russo, A Jardim, E M Carvalho, et al.
Journal of Clinical Microbiology|April 1, 1994
Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigensJ M Peralta, M G Teixeira, W G Shreffler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 1991
Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasisM Barral-Netto, A Barral, S B Santos, et al.
Pageof 17